To more accurately replicate clinical conditions, we developed radioresistant (RR) HNSCC cell lines to study the role of the IL-6/IL-6R/ERK pathway in maintaining EMT and radioresistance in HNSCC. This evidence concerns the gene IL6R and head and neck squamous cell carcinoma.